(1)
Effectiveness and Safety of the Monoclonal Antibody Drug Lecanemab (Leqembi) in Reducing Beta-Amyloid Plaques in Alzheimer’s Dementia: A Literature Review. JOHMPE 2025, 3 (1). https://doi.org/10.52465/johmpe.v3i1.547.